Description
Trade name:
Fluimucil
Compound:
Each effervescent tablet contains:
Acetylcysteine 600 mg
Auxiliary components:
Citric acid anhydrous;
Sodium bicarbonate;
Aspartame;
Lemon flavoring.
Properties:
A mucolytic agent, a derivative of the amino acid cysteine. It has a mucolytic effect, increases the volume of sputum, and facilitates its discharge due to a direct effect on the rheological properties of sputum. The effect of acetylcysteine is associated with the ability of its sulfhydryl groups to break intra- and intermolecular disulfide bonds of acidic mucopolysaccharides of sputum, which leads to depolarization of mucoproteins and a decrease in the viscosity of sputum.
Reduces induced hyperplasia of mucoid cells, enhances the production of surface-active compounds by stimulating type II pneumocytes, stimulates mucociliary activity, which leads to improved mucociliary clearance.
Remains active in the presence of purulent, mucopurulent and mucous sputum.
Indications:
Respiratory diseases and conditions accompanied by the formation of viscous and mucopurulent sputum: acute and chronic bronchitis, tracheitis due to bacterial and/or viral infection, pneumonia, bronchiectasis, bronchial asthma, atelectasis due to blockage of the bronchi by a mucous plug, sinusitis (to facilitate the discharge of secretions), cystic fibrosis (as part of combination therapy).
Preparation for bronchoscopy, bronchography, aspiration drainage.
Removal of viscous secretions from the respiratory tract in post-traumatic and post-operative conditions.
For washing abscesses, nasal passages, maxillary sinuses, middle ear, treatment of fistulas, surgical field during operations on the nasal cavity and mastoid process.
Method of administration and dosage:
Adults and children over 12 years old:
Take 600 mg once a day.
Dissolve 1 tablet in a glass of water and take orally.
Contraindications:
Peptic ulcer of the stomach and duodenum in the acute phase, hemoptysis, pulmonary hemorrhage, lactation period (breastfeeding), hypersensitivity to acetylcysteine.
Contraindicated for use in children under 12 years of age.
Precautions:
Use with caution in the following diseases and conditions: history of gastric ulcer and duodenal ulcer; bronchial asthma, liver and/or kidney failure; histamine intolerance (long-term use should be avoided, since acetylcysteine affects histamine metabolism and can lead to signs of intolerance, such as headache, vasomotor rhinitis, itching); varicose veins of the esophagus; adrenal diseases; arterial hypertension.
When using acetylcysteine in patients with bronchial asthma, it is necessary to ensure drainage of sputum.
An interval of 1-2 hours should be observed between taking acetylcysteine and antibiotics.
The route of administration and the dosage form used must be strictly observed.
Side effects:
Allergic reactions: urticaria, rash, itching, angioedema, anaphylactic reactions, facial swelling.
From the nervous system: headache.
From the organ of hearing and balance: tinnitus.
From the cardiovascular system: tachycardia, decreased blood pressure, bleeding.
From the respiratory system: bronchospasm, dyspnea.
From the digestive system: vomiting, diarrhea, stomatitis, abdominal pain, nausea, dyspepsia.
General reactions: pyrexia.
Storage method:
Store at temperatures not exceeding 25 degrees.
Package:
The cardboard box contains 5 blisters of 2 tablets and paper instructions.
